135 related articles for article (PubMed ID: 17228136)
1. Familial pancreatic cancer: hope can become truth.
Pezzilli R; Fantini L
JOP; 2007 Jan; 8(1):64-6. PubMed ID: 17228136
[No Abstract] [Full Text] [Related]
2. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.
Pogue-Geile KL; Chen R; Bronner MP; Crnogorac-Jurcevic T; Moyes KW; Dowen S; Otey CA; Crispin DA; George RD; Whitcomb DC; Brentnall TA
PLoS Med; 2006 Dec; 3(12):e516. PubMed ID: 17194196
[TBL] [Abstract][Full Text] [Related]
3. [Familial pancreatic cancer and the palladin gene: a new look at cancer mechanisms].
Gilgenkrantz S
Med Sci (Paris); 2007 Mar; 23(3):232-4. PubMed ID: 17349274
[No Abstract] [Full Text] [Related]
4. Familial pancreatic-cancer gene found.
Bradbury J
Lancet Oncol; 2007 Jan; 8(1):14. PubMed ID: 17348120
[No Abstract] [Full Text] [Related]
5. Palladin mutation causes familial pancreatic cancer: absence in European families.
Slater E; Amrillaeva V; Fendrich V; Bartsch D; Earl J; Vitone LJ; Neoptolemos JP; Greenhalf W
PLoS Med; 2007 Apr; 4(4):e164. PubMed ID: 17455999
[No Abstract] [Full Text] [Related]
6. Absence of deleterious palladin mutations in patients with familial pancreatic cancer.
Klein AP; Borges M; Griffith M; Brune K; Hong SM; Omura N; Hruban RH; Goggins M
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1328-30. PubMed ID: 19336541
[TBL] [Abstract][Full Text] [Related]
7. The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer.
Zogopoulos G; Rothenmund H; Eppel A; Ash C; Akbari MR; Hedley D; Narod SA; Gallinger S
Hum Genet; 2007 Jun; 121(5):635-7. PubMed ID: 17415588
[TBL] [Abstract][Full Text] [Related]
8. Selecting families eligible for pancreatic cancer screening: another brick in the wall for the early detection of pancreatic ductal adenocarcinoma and its precursors.
Pezzilli R; Morselli-Labate AM
Dig Liver Dis; 2012 Jul; 44(7):539-40. PubMed ID: 22561444
[No Abstract] [Full Text] [Related]
9. Pancreatic carcinoma surveillance in patients with familial melanoma.
Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
[TBL] [Abstract][Full Text] [Related]
10. ras-oncogene mutation and pancreatic adenocarcinoma.
Das A; Aggarwal R
Indian J Gastroenterol; 1992 Apr; 11(2):101-2. PubMed ID: 1428027
[No Abstract] [Full Text] [Related]
11. Pancreatic cancer surveillance: learning as we go.
Brentnall TA
Am J Gastroenterol; 2011 May; 106(5):955-6. PubMed ID: 21540900
[TBL] [Abstract][Full Text] [Related]
12. Optimizing methods for the diagnosis of pancreatic cancer.
Brugge WR
J Clin Gastroenterol; 2007; 41(10):869-70. PubMed ID: 18090153
[No Abstract] [Full Text] [Related]
13. Inherited predisposition to pancreatic cancer.
Efthimiou E; Crnogorac-Jurcevic T; Lemoine NR; Brentnall TA
Gut; 2001 Feb; 48(2):143-7. PubMed ID: 11156628
[No Abstract] [Full Text] [Related]
14. K-ras as a genetic marker in pancreatic cancer.
Nakayama T; Morishita T; Kamiya T
Acta Gastroenterol Latinoam; 2003; 33(1):43-6. PubMed ID: 14708511
[No Abstract] [Full Text] [Related]
15. Hereditary pancreatic adenocarcinoma. A clinical perspective.
Brand RE; Lynch HT
Med Clin North Am; 2000 May; 84(3):665-75. PubMed ID: 10872423
[TBL] [Abstract][Full Text] [Related]
16. Correspondence re: Seki et al., Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification. Clin. Cancer Res., 7: 1976-1981, 2001.
Hindle KS; Kirkpatrick K; Mokbel K
Clin Cancer Res; 2002 Feb; 8(2):628-9. PubMed ID: 11839686
[No Abstract] [Full Text] [Related]
17. Genetics of pancreatic cancer: where are we now? Where are we going?
Del Chiaro M; Boggi U; Presciuttini S; Bertacca L; Croce C; Mosca I; Mosca F
JOP; 2005 Jan; 6(1 Suppl):60-7. PubMed ID: 15650288
[No Abstract] [Full Text] [Related]
18. JAK V617F missense mutation is absent in pancreatic cancer.
Kocher HM; Mears L; Lea NC; Raj K; Mufti GJ
Gut; 2007 Aug; 56(8):1174-5. PubMed ID: 17625156
[No Abstract] [Full Text] [Related]
19. An unfavourable prognosis for pancreatic cancer indicates fields of opportunity.
Greenhalf W
Gut; 2006 Nov; 55(11):1533-5. PubMed ID: 17047104
[TBL] [Abstract][Full Text] [Related]
20. "PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases.
Leonardi G; Marchi S; Falconi M; Zerbi A; Ussia V; de Bortoli N; Mosca F; Presciuttini S; Del Chiaro M
Dig Liver Dis; 2012 Jul; 44(7):585-8. PubMed ID: 22281375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
